Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels

International Journal of Clinical Practice
J ElgartJ J Gagliardino

Abstract

To examine the relationship between costs of hyperglycaemia drug treatment and glycemic control amongst people with type 2 diabetes (T2D). This observational study utilised data from the QUALIDIAB database on 3,452 T2D patients seen in Diabetes Centers in Argentina. Patients were classified according to their HbA1c value into two groups: on target (OT; HbA1c ≤ 7%), and not on target (NOT; HbA1c > 7%); within each category we considered clinical and metabolic indicators, as well as type of hyperglycaemia treatment. Monthly expenditure on drugs was estimated by micro-costing. Multivariable regression analysis was used to evaluate the association between cost of hyperglycaemia treatment and HbA1c values. In total, 48.9% of the participants have HbA1c OT values. Overall monthly per capita costs of this treatment increased significantly (134%) in the NOT group. Multivariable regression analysis showed that expenditure for hyperglycaemia drugs treatment was significant associated with glycemic control (OR: 0.705), diabetes duration (OR: 1.017), systolic blood pressure (OR: 1.006) and treatment of T2D (OR: 2.622). HbA1c NOT significantly increases drugs monthly cost of hyperglycaemia treatment in people with T2D in a country with an e...Continue Reading

References

Feb 15, 2001·JAMA : the Journal of the American Medical Association·E H WagnerL C Grothaus
Jan 5, 2002·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·J J GagliardinoUNKNOWN Grupo de Investigación de la Red QUALIDIAB
Jul 24, 2002·Diabetologia·R WilliamsUNKNOWN CODE-2 Advisory Board
Oct 19, 2002·BMJ : British Medical Journal·Alastair GrayUNKNOWN United Kingdom Prospective Diabetes Study (UKPDS) Group
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Jul 29, 2003·Diabetes Care·Andrew J KarterUNKNOWN Translating Research Into Action for Diabetes Study Group
Sep 27, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·C M RendersG van der Wal
Jun 22, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Ozturk KaygusuzS Felek
Jan 18, 2006·Cost Effectiveness and Resource Allocation : C/E·Alan K OglesbyMaureen J Lage
Apr 25, 2006·Journal of Diabetes and Its Complications·Andrea MorsanuttoLorenzo Giovanni Mantovani
Sep 6, 2014·International Journal of Public Health·Jorge F ElgartJuan José Gagliardino

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.